AGP Picks
View all

French Guiana Wellness Network
Provided by AGP

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 15, 2026

Antibody Discovery Services Market Outlook 2030: Market Size, CAGR, Trends And Forecast Analysis
Jul. 15, 2026

Antibody Discovery Services Market Outlook 2030: Market Size, CAGR, Trends And Forecast Analysis

Indeterminate EIN Presswire
Anti-Amyloid Antibodies Market Growth Accelerates As Industry Expected To Reach $6.54 Billion By 2030
Jul. 15, 2026

Anti-Amyloid Antibodies Market Growth Accelerates As Industry Expected To Reach $6.54 Billion By 2030

Indeterminate EIN Presswire
Anteroom Containment Systems Market To Reach $2.13 Billion By 2030 Driven By Expanding Industry Demand
Jul. 15, 2026

Anteroom Containment Systems Market To Reach $2.13 Billion By 2030 Driven By Expanding Industry Demand

Indeterminate EIN Presswire
Allosteric Modulators Market Positioned For Sustained Growth At 12.7% CAGR Through 2030
Jul. 15, 2026

Allosteric Modulators Market Positioned For Sustained Growth At 12.7% CAGR Through 2030

Indeterminate EIN Presswire
AchondroplasiAtreatment Market Forecast To Hit $0.97Billion By 2030 Amid Strong Industry Growth
Jul. 15, 2026

AchondroplasiAtreatment Market Forecast To Hit $0.97Billion By 2030 Amid Strong Industry Growth

Indeterminate EIN Presswire
Plasmid Purification Market Worth USD 2.47 Billion in 2026, Projected to Hit USD 4.82Billion by 2033 | CAGR of 11.8%
Jul. 15, 2026

Plasmid Purification Market Worth USD 2.47 Billion in 2026, Projected to Hit USD 4.82Billion by 2033 | CAGR of 11.8%

Indeterminate EIN Presswire
Curaechoice and Symbol Health Solutions Partner to Transform Employer Healthcare with Integrated Onsite Care and Nationwide No-Cost Access
Jul. 15, 2026

Curaechoice and Symbol Health Solutions Partner to Transform Employer Healthcare with Integrated Onsite Care and Nationwide No-Cost Access

Indeterminate GlobeNewswire
Engage Your Destiny Announces Release of When Intelligence Isn't Human, New Book Examining AI's Growing Influence on Faith, Mental Health and Human Relationships
Jul. 15, 2026

Engage Your Destiny Announces Release of When Intelligence Isn't Human, New Book Examining AI's Growing Influence on Faith, Mental Health and Human Relationships

Indeterminate GlobeNewswire
ARCPOINT ANTICIPATES DELAY IN FILING ANNUAL FINANCIAL STATEMENTS
Jul. 15, 2026

ARCPOINT ANTICIPATES DELAY IN FILING ANNUAL FINANCIAL STATEMENTS

Indeterminate GlobeNewswire
A Complete Guide to Pharmaceutical Ingredients: Serum Pharma’s APIs, Plant Extracts & Nutraceutical Solutions
Jul. 15, 2026

A Complete Guide to Pharmaceutical Ingredients: Serum Pharma’s APIs, Plant Extracts & Nutraceutical Solutions

Indeterminate EIN Presswire
Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency
Jul. 15, 2026

Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency

Indeterminate GlobeNewswire
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
Jul. 15, 2026

Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement

Indeterminate GlobeNewswire
Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
Jul. 15, 2026

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy

Indeterminate GlobeNewswire
Rakovina Therapeutics Announces $1.5 Million Private Placement
Jul. 15, 2026

Rakovina Therapeutics Announces $1.5 Million Private Placement

Indeterminate GlobeNewswire
Medicare Covers Online Therapy in New York: MMHC's Medicare-Enrolled Therapists Now Accepting New Patients Statewide at $0 to $27 Per Session
Jul. 15, 2026

Medicare Covers Online Therapy in New York: MMHC's Medicare-Enrolled Therapists Now Accepting New Patients Statewide at $0 to $27 Per Session

Indeterminate GlobeNewswire
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
Jul. 15, 2026

First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

Indeterminate GlobeNewswire
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
Jul. 15, 2026

RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer

Indeterminate GlobeNewswire
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
Jul. 15, 2026

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

Indeterminate GlobeNewswire
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul. 15, 2026

PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul. 15, 2026

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.